Factor XIIIa-catalyzed cross-linking of recombinant alpha C fragments of human fibrinogen

被引:61
作者
Matsuka, YV [1 ]
Medved, LV [1 ]
Migliorini, MM [1 ]
Ingham, KC [1 ]
机构
[1] AMER RED CROSS,J HOLLAND LAB,ROCKVILLE,MD 20855
关键词
D O I
10.1021/bi952294k
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Direct measurements of the structure and function of the COOH-terminal portion of the Aa chain (residues 220-610) of human fibrinogen have been hampered by the difficulty of isolating intact fragments derived from this protease-sensitive region. Here, we overcame this problem by expressing two fragments, alpha C45K (A alpha 221-610) and a truncated version of it, alpha C30K (A alpha 368-610), in Escherichia coli. Both proteins were purified to homogeneous state, and their integrity was confirmed at protein level by sequencing. Upon treatment with factor XIIIa, the alpha C45K fragment but not the alpha C30K fragment formed polymers similar to those derived from fibrin clots. Sequence analysis of cross-linked alpha C45K polymers revealed involvement in the cross-linking reaction of at least three Gln residues (221, 237, 328) in the NH2-terminal region of the fragment and four Lys residues (539, 556, 580, 601) located in the COOH-terminal part of the molecule. In addition, a fraction of alpha C45K fragment was found in an intramolecular cross-linked form, suggesting a high level of flexibility of its polypeptide chain and consistent with the location of its donor and acceptor residues in clusters near the ends of the molecule. The alpha C30K fragment, lacking the NH2-terminal Gln residues, was not able to form polymers or internally cross-linked monomers. Thus, the C-terminal part of the A alpha chain comprises an autonomous, functionally active, and flexible region that plays a key role in alpha polymer formation and stabilization of fibrin clots by factor XIIIa.
引用
收藏
页码:5810 / 5816
页数:7
相关论文
共 35 条
[21]   MOLECULAR-BASIS FOR FIBRINOGEN DUSART (A-ALPHA 554 ARG -] CYS) AND ITS ASSOCIATION WITH ABNORMAL FIBRIN POLYMERIZATION AND THROMBOPHILIA [J].
KOOPMAN, J ;
HAVERKATE, F ;
GRIMBERGEN, J ;
LORD, ST ;
MOSESSON, MW ;
DIORIO, JP ;
SIEBENLIST, KS ;
LEGRAND, C ;
SORIA, J ;
SORIA, C ;
CAEN, JP .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (04) :1637-1643
[22]  
KOOPMAN J, 1992, BLOOD, V80, P1972
[23]  
LIJNEN HR, 1984, THROMB HAEMOSTASIS, V51, P108
[24]  
MAEKAWA H, 1991, J BIOL CHEM, V266, P11575
[25]   THE ROLE OF FIBRINOGEN ALPHA-C-DOMAINS IN THE FIBRIN ASSEMBLY PROCESS [J].
MEDVED, LV ;
GORKUN, OV ;
MANYAKOV, VF ;
BELITSER, VA .
FEBS LETTERS, 1985, 181 (01) :109-112
[26]   HUMAN FIBRINOGEN OF RELATIVELY HIGH SOLUBILITY . COMPARATIVE BIOPHYSICAL BIOCHEMICAL AND BIOLOGICAL STUDIES WITH FIBRINOGEN OF LOWER SOLUBILITY [J].
MOSESSON, MW ;
ALKJAERSIG, N ;
SWEET, B ;
SHERRY, S .
BIOCHEMISTRY, 1967, 6 (10) :3279-+
[27]  
MOSHER DF, 1976, J BIOL CHEM, V251, P1639
[28]   HOW TO MEASURE AND PREDICT THE MOLAR ABSORPTION-COEFFICIENT OF A PROTEIN [J].
PACE, CN ;
VAJDOS, F ;
FEE, L ;
GRIMSLEY, G ;
GRAY, T .
PROTEIN SCIENCE, 1995, 4 (11) :2411-2423
[29]   LABELING OF EPSILON-LYSINE CROSS-LINKING SITES IN PROTEINS WITH PEPTIDE-SUBSTRATES OF FACTOR-XIIIA AND TRANSGLUTAMINASE [J].
PARAMESWARAN, KN ;
VELASCO, PT ;
WILSON, J ;
LORAND, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (21) :8472-8475
[30]   CROSS-LINKING OF ALPHA-2-PLASMIN INHIBITOR TO FIBRIN BY FIBRIN-STABILIZING FACTOR [J].
SAKATA, Y ;
AOKI, N .
JOURNAL OF CLINICAL INVESTIGATION, 1980, 65 (02) :290-297